SCINTIMUN® 1 mg

SCINTIMUN® 1 mg

Kit for radiopharmaceutical preparation for the labelling of besilesomab with
technetium (99mTc)
Each vial 1 contains 5.02 mg dry substance : Besilesomab 1 mg
Disodium hydrogen phosphate, anhydrous
Sodium dihydrogen phosphate, anhydrous
Under nitrogen atmosphere
Sorbitol E420
Each vial 2 contains 2.82 mg dry substance :
1,1,3,3-propane tetraphosphonic acid,
tetrasodium salt, dihydrate (PTP) 2.7 mg
Tin (II) chloride dihydrate
Sodium hydroxyde 1N (pH adjustment)
Hydrochloric acid 1N (pH adjustment)
Under nitrogen atmosphere
Volume of pertechnetate 99mTc to use for reconstitution into vial: 1 2 to 7 mL
Radiochemical purity: _ 95 %
Storage: 2 years at 2 – 8°C, protected from light
Stability of labelled product: 3 h not above 25°C, protected from light
Activity per vial 400 to 1800 MBq
Indications /Posology In conjunction with other appropriate imaging modalities
determination of the location of inflammation/infection peripheral
bone in adults with suspected osteomyelitis (400-800 MBq).
Time between injection and examination 3 to 6h and late image 24h
Availability From stock
Number of radiolabelled preparations per kit 2

Loading...

Email news feed

Insert the following characters: captcha